Seres Health gets $10M for drugs to rebalance the body’s bacteria

A week after naming a new CEO, a Cambridge-based startup working on drugs that work in the millions of bacteria in the body has raised $10 million and has an exclusive research collaboration with the Mayo Clinic...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.